Texas Rare Earth Resources Corp (TRER) 0.2950 $TRER My

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Texas Rare Earth Resources Corp (TRER) 0.2950 $TRER

My Interview With Texas Rare Earth Resources' Jack Lifton, Dan Gorski, And Anthony Marchese
Ben Kramer-Miller - Seeking Alpha - Mon Jun 15, 2:55PM CDT
Last week I had the opportunity to interview three board members of Texas Rare Earth Resources ( OTCQX:TRER ): Anthony Marchese, Jack Lifton, and Dan Gorski. TRER is a company that largely flies under the radar. I was fortunate enough to have the...

Texas Rare Earth Resources to Present at the LD Micro Invitational Conference on June 3rd
Marketwired - Thu May 28, 6:01AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, today announced that Anthony Marchese, Chairman of the Board, will present at the LD Micro Conference on June 3rd, 2015 at 10:00 a.m. PDT in Los Angeles.

Texas Rare Earth Resources Successfully Produces Commercially Marketable Mid/Heavy Rare Earth Concentrate
Marketwired - Tue May 26, 5:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER)

Texas Rare Earth Resources: Round Top And CIX/CIC Get A Major Vote Of Confidence
Ben Kramer-Miller - at Seeking Alpha - Wed Apr 08, 1:15PM CDT


Texas Rare Earth Resources to Present at the 2nd Annual Growth Capital Expo on April 14th
Marketwired - Tue Apr 07, 6:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, today announced that Anthony Marchese, Chairman of the Board, will present at the 2nd Annual Growth Capital Expo 2015 Conference on April 14, 2015 at 12:30 p.m. PDT in Las Vegas.

Texas Rare Earth Resources and AREVA Subsidiary Sign Uranium Offtake Agreement
Marketwired - Mon Apr 06, 5:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER)

Reminder: Texas Rare Earth Resources to Present Today at the John Tumazos Very Independent Research Metals and Natural Resources Conference
Marketwired - Mon Mar 30, 6:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, today announced that Anthony Marchese, Chairman of the Board, will present today at the John Tumazos Very Independent Research, LLC Metals and Natural Resources Conference at 2:10 p.m. EST in NYC. The Conference will be available via webcast.

Texas Rare Earth Resources to Present at the John Tumazos Very Independent Research Metals and Natural Resources Conference on March 30th
Marketwired - Wed Mar 25, 6:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, today announced that Anthony Marchese, Chairman of the Board, will present at the John Tumazos Very Independent Research, LLC Metals and Natural Resources Conference on Monday, March 30st at 2:10 p.m. EDT in NYC. The Conference will be available via webcast.

'60 Minutes' Tackles Rare Earths
Ben Kramer-Miller - at Seeking Alpha - Mon Mar 23, 5:07AM CDT

GE: 26.27 (+0.25), GM: 31.40 (+0.39), MCP: 0.36 (unch), AAPL: 123.28 (+3.21), REE: 0.41 (+0.01)

CBS "60 Minutes" Interviews Texas Rare Earth Resources Advisory Board Member in Rare Earth Story
Marketwired - Mon Mar 23, 5:00AM CDT
Texas Rare Earth Resources Corp. (OTCQX: TRER)

Texas Rare Earth Resources: Getting Specific With CEO Dan Gorski
Ben Kramer-Miller - at Seeking Alpha - Sat Feb 28, 8:19AM CST


Apple's Dirty Little Rare Earth Secret
Ben Kramer-Miller - at Seeking Alpha - Thu Feb 19, 4:36PM CST

MXIM: 32.27 (+0.24), SWKS: 100.20 (+5.69), LLTC: 43.04 (+0.56), TAS: 0.46 (+0.04), INTC: 29.17 (+0.24), MCP: 0.36 (unch), ADI: 61.51 (+0.62), AAPL: 123.28 (+3.21), AVGO: 129.84 (+5.16), REE: 0.41 (+0.01)

Update: Texas Rare Earth Resources Moves On To Stage 2 Of Its 3-Stage REE Separation Process, SC Capital Acquires 825,000 Shares
Ben Kramer-Miller - at Seeking Alpha - Thu Feb 05, 3:04PM CST


Texas Rare Earth Resources Advances Round Top Hydrometallurgical Development
Marketwired - Wed Feb 04, 5:00AM CST
Texas Rare Earth Resources Corp. (OTCQX: TRER)

Texas Rare Earth Resources Announces Completion of Rights Offering
Marketwired - Mon Jan 26, 1:08PM CST
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, today announced that it has completed its previously announced rights offering. The Company raised approximately $940,000 in aggregate gross proceeds, before expenses, through shareholder subscriptions for 4,272,270 Units including the exercise of over-subscription rights. Each Unit consisting of one share of the Company's common stock, one five year non-transferable Class A warrant exercisable for one share of the Company's common stock at $0.35 per share and one five-year non-transferable Class B warrant exercisable for one share of the Company's common stock at $0.50 per share.

Texas Rare Earth Resources: Advancing Metallurgy And Reason-Defying Valuation Make This Best In Breed REE Junior A Buy
Ben Kramer-Miller - at Seeking Alpha - Wed Jan 14, 8:23AM CST

REE: 0.41 (+0.01)

Texas Rare Earth Resources Announces Extension of Rights Offering to January 21st
Marketwired - Tue Jan 13, 5:00AM CST
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company specializing in the heavy rare earths, announces an extension of the deadline to subscribe to its previously announced rights offering to 5 PM EST, January 21, 2015. TRER is extending its rights offering subscription period because the holiday season created delays in the distribution of the rights to certain holders of the company holding their shares of common stock through broker-dealers and other nominees. Many shareholders have just recently received their rights certificates or instructions from their brokers on how to exercise their rights. To ensure that these holders have adequate time to consider the rights and complete their subscriptions, TRER has determined to extend the exercise period for one week. The majority of management and the board of directors plan to participate in the rights offering.

Reminder: Texas Rare Earth Resources Tuesday, January 6th Live Roadshow Presentation With Webcast
Marketwired - Mon Jan 05, 8:05AM CST
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company targeting heavy rare earth minerals, wishes to remind everyone about a live roadshow presentation on Tuesday, January 6th, 2015 in midtown New York City in relation to the Company's ongoing rights offering. The presentation will be webcast and dial-in numbers provided for those not able to attend in person but will not be recorded or otherwise available or archived after the live presentation. Participants and dial-in guests will be given the opportunity to ask questions.

Update: Texas Rare Earth Resources Names Eric Noyrez To Its Board Of Directors
Ben Kramer-Miller - at Seeking Alpha - Wed Dec 31, 7:18AM CST


Texas Rare Earth Resources Announces January 6th Live Roadshow Presentation
Marketwired - Wed Dec 31, 6:00AM CST
Texas Rare Earth Resources Corp. (OTCQX: TRER), an exploration company targeting heavy rare earth minerals, announced today a live roadshow presentation on January 6th, 2015 in midtown New York City in relation to the Company's ongoing rights offering. The presentation will be webcast and dial-in numbers provided for those not able to attend in person but will not be recorded or otherwise available or archived after the live presentation. Participants and dial-in guests will be given the opportunity to ask questions.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 938

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 309

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 261

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonic Partners with Obsessed Garage for Home Garage Solutions

Updated Category News Views 147

Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...

Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline

Updated Category News Views 167

Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...

Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights

Updated Category News Views 67

XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...

Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures

Updated Category News Views 230

Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....

Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed

Updated Category News Views 56

Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...

Continue Reading